These findings highlighted that cells from various maturation stages possess the ability to engraft B-ALL and contain stem cell activity, as both CD19+/CD20− and CD19+/CD20+ cells were shown to successfully engraft B-ALL. Here, CD19 is linked to acute lymphoblastic leukemia.